Abstract

Tacrolimus Monohydrate 1 mg/mL in SyrSpend SF pH4

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2019 - Volume 23, Number 6

Page(s): 491

Download in electronic PDF format for $75
  • Tacrolimus Monohydrate 1 mg/mL in SyrSpend SF pH4 Page 1

Abstract

A formulation for preparing Tacrolimus Monohydrate 1 mg/mL in SyrSpend SF pH4. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • tacrolimus
  • formulation
  • immunosuppressant
  • macrolide calcineurin inhibitor
  • anti-inflammatory agent
  • inflammation
  • ulcerative colitis
  • interleukin 2 inhibitor
  • T cell–mediated disorders
  • transplant rejection

Related Categories

  • EXCIPIENTS
  • FORMULATIONS
  • ALLERGY/IMMUNOLOGY/INFLAMMATION

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2019
Pg. 491
Tacrolimus Monohydrate 1 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Mar/Apr 2004
Pg. 101-105
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs
Author(s): Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K
May/Jun 2020
Pg. 229
Prednisolone 1 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Jul/Aug 2020
Pg. 315
Hydrocortisone Hemisuccinate 2 mg/mL or Hydrocortisone Sodium Phosphate 2 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
May/Jun 2021
Pg. 234
Tacrolimus 0.5 mg/mL in Ora-Plus and Simple Syrup Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2019
Pg. 490
Sulfasalazine 100 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Nov/Dec 2018
Pg. 516-526
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4
Author(s): Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
Mar/Apr 2019
Pg. 153
Tacrolimus 0.5 mg/mL in Oral Mix Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2017
Pg. 416
Tacrolimus 0.3-mg/mL Ophthalmic Solution
Author(s): Allen Loyd V Jr
Jul/Aug 2015
Pg. 333
Tacrolimus Capsules, 0.5 mg, 1 mg, or 5 mg
Author(s): Allen Loyd V
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Jan/Feb 2019
Pg. 53
Ketoprofen 20-mg/mL in SyrSPend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
May/Jun 2020
Pg. 225
Dexamethasone 1 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Jul/Aug 2017
Pg. 319
Tacrolimus 0.06% Ophthalmic Drops
Author(s): Allen Loyd V Jr
Jul/Aug 2021
Pg. 328
Tacrolimus 0.1% Topical Microemulsion
Author(s): Allen Loyd V Jr
Mar/Apr 2022
Pg. 145
Naproxen 25 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Nov/Dec 2016
Pg. 510
Imatinib 40-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2016
Pg. 167-174
Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions
Author(s): Polonini HC, Loures S, Lima LC, Ferreira AO, Brandão MA